Trending: Roche to Buy Carmot Therapeutics in Deal Worth Up to $3.1 Billion
05 12월 2023 - 12:12AM
Dow Jones News
9:42 ET -- Roche is one of the most mentioned companies in the
U.S. across all news items in the last 12 hours, according to
Factiva data. The Swiss pharmaceutical company announced a deal to
buy Carmot Therapeutics for $2.7 billion with up to $400 million in
additional payments based on drug-development milestones. Roche
said it would be gaining Carmot's research-and-development
portfolio, including drugs it's developing to treat obesity and
type-1 and type-2 diabetes. Dow Jones & Co. owns Factiva.
(susan.solan@wsj.com)
(END) Dow Jones Newswires
December 04, 2023 09:57 ET (14:57 GMT)
Copyright (c) 2023 Dow Jones & Company, Inc.
Roche (QX) (USOTC:RHHBY)
과거 데이터 주식 차트
부터 6월(6) 2024 으로 7월(7) 2024
Roche (QX) (USOTC:RHHBY)
과거 데이터 주식 차트
부터 7월(7) 2023 으로 7월(7) 2024
Roche Holdings Ltd AG (QX) (OTC 시장)의 실시간 뉴스: 최근 기사 0
More Roche Holdings Ltd AG (QX) News Articles